Company intelligence / Profile preview

Kandu, Inc.

Campbell, California, USAkanduhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kandu’s integrated platform combines the FDA-cleared IpsiHand brain-computer interface system with a telehealth-enabled clinical support program. Clinical results show that approximately 70% of IpsiHand users experienced improved arm and hand function after 12 weeks, and 80% of patients achieved independent living at 90 days. Early data also indicate low hospital readmission rates among participants[5][7].

Therapeutic areas: Neurology
Modalities: DeviceDigital health platformBrain-computer interface
Industry: Therapeutic Medical Devices

Partnerships

Neurolutions (now merged)Imperative Care

Beyond the preview

Go deeper on Kandu, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kandu, Inc..

Explore the full profile